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Background: National and international evidence-based guidelines for hip and knee osteoarthritis recommend to
start with (a combination of) conservative treatments, followed by surgical intervention if a patient does not
respond sufficiently to conservative treatment options. Despite these recommendations, there are strong indications
that conservative treatments are not optimally used in orthopedic practice. Our study aims to quantify the use of
conservative treatments in Dutch orthopedic practice and to explore the barriers and facilitators for the use of
conservative treatments that should be taken into account in a strategy to improve the embedding of conservative
treatments in hip and knee osteoarthritis in orthopedic practice.
Methods: This study consists of three phases. First, current use of conservative treatments in patients with hip and
knee osteoarthritis will be explored using an internet-based survey among at least 100 patients to identify the
underused conservative treatments. Second, barriers and facilitators for the use of conservative treatments in
orthopedic practice will be identified using semi-structured interviews among 10 orthopedic surgeons and 5 patients.
The interviews will be followed by an internet-based survey among approximately 450 orthopedic surgeons and at
least 100 patients in which the identified barriers and facilitators will be ranked by importance. Finally, an
implementation strategy will be developed based on the results of the previous phases using intervention mapping.
Discussion: The developed strategy is likely to result in an optimal and standardized use of conservative treatment
options in hip and knee osteoarthritis in orthopedic practice, because it is focused on identified barriers and facilitators.
In addition, the results of this study can be used as an example for optimizing the use of conservative care in other
patient groups. In a subsequent study, the developed implementation strategy will be assessed on its
effectiveness, feasibility and costs.
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Osteoarthritis (OA) is a degenerative joint disease primar-
ily characterized by progressive loss of articular cartilage.
It leads to pain and loss of function [1]. Approximately
10% of men and 18% of women older than 60 years have
OA [2]. Symptomatic OA of the knee and the hip have the
highest prevalence within the group of arthritis. Due to
the ageing society and obesity, the prevalence of hip and
knee OA is still increasing [3].
In 2009, 154 patients per 100,000 persons received a
Total Hip Arthroplasty (THA) or Total Knee Arthroplasty
(TKA), and 118 patients per 100,000 persons received a
TKA in Western countries [4]. However, the lifespan of a
prosthesis is limited. The revision rate after a TKA or
THA is 12.9% after 10 years [5], and revision arthroplasty
is less successful than primary TKA or THA [6]. There-
fore, it is important to delay the primary TKA or THA by
optimizing the use of conservative treatment options,
especially in young people.
National and international evidence-based guidelines
for hip and knee OA recommend to start with (a com-
bination of ) conservative treatments [7-11]. Conservative
treatments include pharmacological options (e.g., the use
of analgesics, non-steroidal anti-inflammatory drugs, and
steroid injection therapy) and non-pharmacological op-
tions (e.g., physical therapy, patient education, and wait
loss intervention). Conservative treatments aim to prevent
progression and reduce symptoms such as joint pain and
impairment of functions [11]. If persons do not respond
(sufficiently) to conservative treatment options, joint
replacement (i.e., THA or TKA) can be considered. Des-
pite the recommendation in guidelines to start with con-
servative treatments and only use surgical intervention
if a patient does not respond sufficiently to conservative
treatment options, the use of conservative treatments in
daily practice is suboptimal [12-15]. For example, a
study showed that conservative treatments were not
fully exploited in 81% of the patients who were referred
to specialized knee/hip OA outpatient clinics [12]. In-
formation about conservative treatments patients re-
ceive in orthopedic practice is lacking. Furthermore,
surgery rates are rising [16]. TKA and THA in patients
with OA increased with 196% and 50% respectively be-
tween 1995 and 2005 in the Netherlands [16]. In addition,
large variation exists in preoperative status (e.g., disease se-
verity) across different centers in Europe and Australia,
which suggests differences in the timing of surgery
[17,18]. Optimal use of conservative treatments could
reduce these differences.
A few models of care were developed to optimize the
use of conservative treatments. In Australia, a clinical
pathway model and clinician and patient toolkits were
developed to support implementation of nonsurgical
management of hip and knee OA [19]. However, inAustralia, rheumatologists play a leading role, while in
the Netherlands, the orthopedic surgeon is responsible
for OA treatment in hospital care. In the Netherlands, a
stepped-care strategy (SCS) based on (inter)national
guidelines [20,21] is developed to facilitate the use of
conservative treatments in three steps in primary care
[22,23]. The first step consists of education, life style
advice, and acetaminophen. If the treatment options in
the first step are not sufficient, treatment options in the
second step can be considered (exercise therapy, dietary
therapy, and non-steroidal anti-inflammatory drugs).
Multidisciplinary care, intra-articular injections, and
transcutaneous electrical nerve stimulation are treat-
ment options in the third step and could be considered
if treatment options in step one or two are ineffective.
After implementation of the SCS, most recommended
conservative treatments seem to be well used, except
dietary therapy [23]. Both studies provide evidence to
promote the use of conservative treatments in primary
care or in a setting where the rheumatologists play a
leading role, but strategies for the optimization of conser-
vative treatments in orthopedic care are still lacking. Infor-
mation about the current use of conservative treatments,
and barriers and facilitators influencing the adoption of
conservative treatments in orthopedic practice, is needed
to develop a tailored implementation strategy focused on
orthopedic care.
In the Netherlands, patients with OA are usually treated
by the general practitioner. According to guidelines, pa-
tients should be referred to the orthopedic surgeon if they
do not respond sufficiently to conservative treatment
options. In orthopedic practice, the decision will be
made to start/continue conservative treatments or to
perform a surgery depending on previous received
treatments and disease severity. The leading role of an
orthopedic surgeon could result in other barriers and
facilitators compared to a setting where the rheuma-
tologists play a leading role. This subsequently results
in another strategy to improve the embedding of con-
servative therapies in hip and knee OA in orthopedic
practice. While rheumatologists and general practi-
tioners only provide conservative treatments in OA,
orthopedic surgeons can provide both conservative
treatments and surgical interventions. It is unclear to
what extent factors such as lack of information about
conservative treatment options, increasing number of
orthopedic surgeons [16], or patient preferences play a
role. It is important to explore these factors for the
development of a tailored implementation strategy, so
that orthopedic surgeons will provide underused treat-
ment options in primary care, such as dietary therapy.
Part of this implementation strategy could be the SCS
or a clinical pathway model as used in previous
implementations.
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The BART-OP study (Beating osteoARThritis in the
Orthopedic Practice) aims to quantify the use of conserva-
tive treatments in Dutch orthopedic practice before THA
or TKA and to explore the barriers and facilitators for the
use of conservative treatments that should be taken into
account in a strategy to improve the embedding of conser-
vative treatments in hip and knee OA in orthopedic
practice.
To reach the aim of this study, we formulated the
following research questions:
1. What is the current use of conservative treatments,
before patients receive a surgery, in orthopedic
practice?
2. Which barriers and facilitators influence the use of
conservative treatments in orthopedic practice?
3. What is an appropriate tailored implementation
strategy for the embedding of conservative
treatments in orthopedic practice?
In a subsequent study, the developed implementation
strategy will be assessed on its effectiveness, feasibility and
costs.
Methods
This study consists of three phases to be executed in
one year:
A. The analysis of current use of conservative
treatments, before patients receive a surgery in
orthopedic practice (months 1 to 9).
B. Identification of barriers and facilitators for
non-optimal conservative treatments, using two
steps (months 1 to 9).
i. Barriers and facilitators for non-optimal
conservative treatments are explored with
interviews among orthopedic surgeons and
patients.
ii. Identified barriers and facilitators are ranked by
importance in a survey among a representative
sample of orthopedic surgeons and patients.
C. The development of the implementation strategy based
on the results of phases A and B (months 9 to 12).
The study design, study population, analysis and out-
come measures are described per study phase.
Phase A. The analysis of current use of conservative
treatments before patients receive a surgery in
orthopedic practice
Study design
To analyze the current use of conservative treatments,
before patients undergo THA or TKA in orthopedicpractice, an internet-based survey among patients will be
performed. The survey will include questions about
which conservative treatment options are used before
surgery. This information is needed to be able to focus
the implementation strategy on the right conservative
treatments. The content of the survey will be developed
based on the Dutch guideline of OA of the hip and knee
[11]. Reminders to non-responders will be sent after two
weeks and again after four weeks.
Study population
The survey will be sent to a sample of at least 100 patients
living in different regions of the Netherlands. Inclusion
criteria for patients are: age ≥18 years, a doctor’s diagnosis
of hip or knee OA, and who have had a TKA or THA
no longer than 12 months ago or are on the waiting list
for surgery within the next 3 months. Patients with an
inability to understand written Dutch will be excluded
from the study. We will sample these patients using
advertisements in local newspapers, and at websites or
newsletters of patient associations.
Analysis
Descriptive statistics will be used to describe the current
use of conservative treatment options in orthopedic
practice. Independent t-tests or Mann Whitney U tests
for continuous variables and Chi square tests or Fisher’s
exact tests for proportions are used to analyze differences
in the frequency of use between different regions or other
conditions.
Outcome measures
The main outcome measure is the percentage of patients
in whom the conservative treatment options are applied
optimally before they undergo surgery, as described in
the guideline. These results will help us to focus the im-
plementation strategy, developed in phase C, on the
right conservative treatments.
Phase B. Identification of barriers and facilitators for
non-optimal treatment
Study design
Two steps will be taken to identify barriers and facilitators
associated with the non-optimal use of conservative treat-
ments. First, semi-structured interviews among orthopedic
surgeons and patients will be performed to explore all
relevant barriers and facilitators for non-optimal conserva-
tive therapy. The interview questions will be based on the
Theoretical Domains Interview framework (TDI) [24].
The TDI framework includes 12 theoretical construct do-
mains derived from 33 psychological theories and covering
128 explanatory constructs that enhance implementation
of evidence-based practice [24]. In addition, barriers and
facilitators reported in a previous study about the use of
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[25] are included in the interview questions. Second, an
internet-based survey will be held among a selection of
orthopedic surgeons (n≈400) and sample of patients
(n≥100) to rank barriers and facilitators identified in
the interviews on importance. The survey will include
questions to determine which of these barriers and fa-
cilitators are associated with the use of conservative
treatments.
Study population
For the semi-structured interviews, we anticipate inter-
viewing 10 orthopedic surgeons involved in hip and knee
surgery and 5 patients who have had a THA or TKA no
longer than 12 months ago (≥18 years, and able to
understand oral Dutch). If we do not reach data satur-
ation after these interviews (three consecutive interviews
without new barriers or facilitators [26]), we will con-
tinue interviewing until data saturation is reached. To
obtain contrasting views on barriers and facilitators, we
will apply purposive sampling. First, we will purposively
select orthopedic surgeons and patients from Dutch
regions with high surgery rates and from Dutch regions
with relatively low surgery rates based on the report of
Van Beek et al. about variation in clinical practice [27].
In addition, we will select orthopedic surgeons in such a
way as to ensure diversity of hospital type (public hospi-
tals and academic hospitals). It is important to include
orthopedic surgeons of public and academic hospitals,
because this may reveal other facilitators and barriers.
For the internet-based survey, Dutch orthopedic sur-
geons listed in the registry of the Dutch Orthopedic As-
sociation (NOV) or the Dutch medical address book will
be approached for participation. Inclusion criteria are:
involved in hip or knee OA, and access to email address.
Patients (n≥100) are recruited using advertisements in
local newspapers. Included are patients: ≥18 years who
have had total hip or knee surgery no longer than
12 months ago, or are on the waiting list for receiving a
THA or TKA. Patients with an inability to understand
oral Dutch will be excluded from the study.
Analysis
The semi-structured interviews will be audio-taped and
transcribed in full for analysis. The interviews will be an-
alyzed by two researchers using open coding to ensure
that we find all barriers and facilitators for the non-
optimal use of conservative therapy. This qualitative
analysis will be executed using the software package
ATLAS.ti (ATLAS.ti Scientific Software Development
GmBH, Berlin, Germany) for this qualitative analysis.
The subsequent survey data will allow us to rank the
importance of barriers and facilitators and their relation-
ship with the use of conservative treatments. Theserelationships will be assessed using multiple regression
analysis. We will use SPSS 20.0 for analysis.Outcome measures
A list of the most relevant barriers and facilitators for
the optimal use of conservative treatments in orthopedic
practice before patients with hip or knee OA receive
THA or TKA.C. The development of the implementation strategy
Study design
The results of the previous phases will be used to de-
velop a tailored implementation strategy for the optimal
use of conservative treatments in orthopedic practice in
patients with hip or knee OA. The results of phase A
will show at which type(s) of conservative treatment the
strategy should be aimed. Phase B results will show the
most relevant barriers and facilitators that should be
taken into account in the development of the strategy.
From literature, it is known that, in general, multifa-
ceted strategies are more effective than single strategies
[28,29]. Assuming this, and our expectation that several
barriers on different theoretical domains will be found,
it is very likely that the developed implementation strat-
egy includes several components directed at different
levels (i.e., knowledge or social influences). Furthermore, it
is expected that the strategy components will include edu-
cational outreach, an interactive educational strategy, and/
or patient-specific strategies, because these facets seem to
be promising for implementation [28].
In the development process, the project team will use
the intervention mapping approach of Bartholomew et al.
[30]. This method begins with the creation of matrices,
in which the performance objectives are set against the
most important factors that hinder or facilitate the
adoption of conservative treatments. Subsequently, the
project team will brainstorm about the strategy compo-
nents needed to achieve the performance objective in
the presence of the barrier or facilitator mentioned in
the matrix. The cells of the matrices are then gradually
filled with implementation strategy components [30].
Next, the project team will translate the formulated
strategy components into practical strategies.Analysis
The study group meeting will be summarized. The pro-
ject members will receive a summary of the meeting
and the formulated implementation strategy and will
be asked whether the summary and implementation
strategy is consistent with the conclusions reached in
the meeting.
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A tailored implementation strategy for the embedding of
conservative treatments in orthopedic practice in patients
with hip or knee OA.
Ethical approval
This study protocol was presented to the Medical Ethical
Committee of the Leiden University Medical Center
(CME P13.087/NV/nv). An exemption was obtained, as
ethical approval for this type of study is not required
under Dutch law.
Discussion
The goal of this study is to develop a tailored imple-
mentation strategy to optimize the use of conservative
treatments in hip and knee OA in patients referred to
the orthopedic surgeon.
Several studies have been performed to develop and
test implementation strategies, including identification
of barriers that prevent implementation [31-33]. They all
conclude that a prior inventory of barriers to develop a
tailored implementation strategy is useful and can con-
firm whether barriers differ in different settings. Prior
inventory thereby reduces the number of costly trials
evaluating different implementation strategies [28,32,34].
Although previous studies already explored barriers for
the use of conservative treatments, these studies were
performed in other settings, and not focused on ortho-
pedic care. Furthermore, the uptake of several imple-
mentation activities was poor, since only 9% of the
participating GPs were present at the seminar [23]. It
was very difficult to reach all GPs in seminars. This
could be easier in orthopedic practice. Orthopedic sur-
geons may have more interest in OA, because it is part
of their specialization, whereas for GPs it is one of the
many health problems in their daily practice. This high-
lights the importance of optimizing the use of conserva-
tive treatments in orthopedic practice as well, so that
patients will receive optimal treatment options in ortho-
pedic practice if conservative care was suboptimal in
their primary care trajectory. Our study and the study
performed in primary care together will provide useful
information for the development of interventions based
on the full spectrum of barriers and facilitators in primary
care and orthopedic practice. This is important because a
multidisciplinary approach is likely to be more effective to
obtain optimal conservative therapy [35].
A strength of this study is the purposive sampling of
orthopedic surgeons of regions with low and high sur-
gery rates, because they could have contrasting views on
barriers and facilitators. We think that this will reveal
most barriers and facilitators for the implementation of
the optimal use of conservative treatments in hip and
knee OA in orthopedic practice. A limitation may be theselection of patients. Patients will be recruited via adver-
tisement, which can lead to selection bias, because pa-
tients who respond to the advertisements may perceive
other barriers and facilitators as most important com-
pared to non-responders. Furthermore, the use of an
internet-based survey could also induce selection bias.
Knee and hip OA increases with age [3], but not all eld-
erly persons do have internet or an email address. This
can lead to the selection of younger persons compared
to the average age of OA patients, while elderly persons
may perceive other barriers and facilitators as most
important. We will assess the impact of selection bias by
comparing elderly respondents with younger ones. If
they perceive the same barriers and facilitators, we can
conclude that the impact of this type of selection bias
does not influence our results.
The developed strategy is likely to result in an optimal
and standardized use of conservative treatment options
in hip and knee OA in orthopedic practice. In addition,
the results of this study can be used as an example for
optimizing the use of conservative care in other patient
groups. In a subsequent study, the developed implemen-
tation strategy will be assessed on its effectiveness, feasi-
bility and costs.
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